IRIS
CERCHIA, CARMEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 517
EU - Europa 350
AS - Asia 94
AF - Africa 25
SA - Sud America 1
Totale 987
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 512
IT - Italia 226
CN - Cina 74
IE - Irlanda 32
NL - Olanda 30
CI - Costa d'Avorio 25
FI - Finlandia 17
GB - Regno Unito 10
SE - Svezia 9
DE - Germania 8
TR - Turchia 7
CA - Canada 5
FR - Francia 5
IN - India 5
VN - Vietnam 4
ES - Italia 3
RS - Serbia 3
NP - Nepal 2
RU - Federazione Russa 2
BD - Bangladesh 1
BE - Belgio 1
CL - Cile 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
LV - Lettonia 1
Totale 987
Salva come PNG Salva come JPEG
Città #
Chandler 93
Ashburn 47
Napoli 45
Millbury 43
Naples 35
Amsterdam 30
Des Moines 29
Beijing 24
Princeton 20
Lawrence 16
Salerno 16
Nanjing 15
Boston 13
Wilmington 11
Hebei 6
Shenyang 6
Falls Church 5
Guangzhou 5
Ottawa 5
Buccino 4
Dong Ket 4
Enfield 4
Fairfield 4
Frankfurt am Main 4
Milan 4
Nanchang 4
Pune 4
Redwood City 4
Rome 4
Çanakkale 4
Busto Arsizio 3
Casavatore 3
Changsha 3
Jiaxing 3
Norwalk 3
Sevilla 3
Agropoli 2
Ann Arbor 2
Bari 2
Bastia umbra 2
Belgrade 2
Catanzaro 2
Dublin 2
Genova 2
Lubhu 2
Mablethorpe 2
Messina 2
Oristano 2
Palermo 2
Pisa 2
Redmond 2
Seattle 2
Siano 2
Siena 2
Stockholm 2
Tianjin 2
Yellow Springs 2
Atlanta 1
Baronissi 1
Belmonte Mezzagno 1
Benevento 1
Boardman 1
Bonn 1
Brussels 1
Caserta 1
Casoria 1
Castellammare Di Stabia 1
Cava De' Tirreni 1
Cernobbio 1
Cerro Maggiore 1
Chiampo 1
Chittagong 1
Comiziano 1
Dallas 1
Dugenta 1
Emeryville 1
Ennepetal 1
Fisciano 1
Hangzhou 1
Hayes 1
Irakleio 1
Istanbul 1
Jinan 1
Kiel 1
Kronberg 1
La Canada Flintridge 1
Lappeenranta 1
Los Angeles 1
Maniago 1
Marano di Napoli 1
Mondolfo 1
New Delhi 1
Nola 1
Novi Sad 1
Olomouc 1
Pannarano 1
Rende 1
Riga 1
Salandra 1
San Francisco 1
Totale 611
Salva come PNG Salva come JPEG
Nome #
Novel Non-Peptide Small Molecules Preventing IKKβ/NEMO Association Inhibit NF-κB Activation in LPS-Stimulated J774 Macrophages 52
A compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative ability 50
Cdc25 inhibitors in melanoma cells 47
App maturation and intracellular localization are controlled by a specific inhibitor of 37/67 kda laminin-1 receptor in neuronal cells 46
Ligand-based chemoinformatic discovery of a novel small molecule inhibitor targeting CDC25 dual specificity phosphatases and displaying in vitro efficacy against melanoma cells 45
Discovery of Novel Naphthylphenylketone and Naphthylphenylamine Derivatives as Cell Division Cycle 25B (CDC25B) Phosphatase Inhibitors: Design, Synthesis, Inhibition Mechanism, and in Vitro Efficacy against Melanoma Cell Lines 44
Discovery of a Novel Small Molecule Inhibitor Targeting the Frataxin/Ubiquitin Interaction via Structure-Based Virtual Screening and Bioassays 43
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities 42
In silico methods to address polypharmacology: Current status, applications and future perspectives 36
The antiproliferative and proapoptotic effects of cladosporols A and B are related to their different binding mode as PPARγ ligands 36
Easy access to α-ketoamides as SARS-CoV-2 and MERS Mpro inhibitors via the PADAM oxidation route 32
Discovery Of Novel Peroxisome Proliferator-Activated Receptor γ (PPARγ) Scaffolds With Partial Agonist Binding Properties By Integrated In Silico/In Vitro Work Flow 32
Small Molecule Drugs And Targeted Therapy For Melanoma: Current Strategies And Future Directions 32
SARS-CoV-2 Entry Inhibitors: Small Molecules and Peptides Targeting Virus or Host Cells 31
Antitumor agents 7. Synthesis, antiproliferative activity and molecular modeling of new L-lysine-conjugated pyridophenoxazinones as potent DNA-binding ligands and topoisomerase IIα inhibitors 31
Identification of a new series of amides as non-covalent proteasome inhibitors 29
Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination 28
Exploring the Role of N(6)-Substituents in Potent Dual Acting 5'-C-Ethyltetrazolyladenosine Derivatives: Synthesis, Binding, Functional Assays, and Antinociceptive Effects in Mice 26
null 26
Development of Novel Selective Peptidomimetics Containing a Boronic Acid Moiety, Targeting the 20S Proteasome as Anticancer Agents 25
New diphenylmethane derivatives as peroxisome proliferator-activated receptor alpha/gamma dual agonists endowed with anti-proliferative effects and mitochondrial activity 24
In Silico Identification of Novel Inhibitors Targeting the Homodimeric Interface of Superoxide Dismutase from the Dental Pathogen Streptococcus mutans 23
Structural basis for PPAR partial or full activation revealed by a novel ligand binding mode 22
Selective PPARγ modulators for Type 2 diabetes treatment: How far have we come and what does the future hold? 19
Characterization of novel inhibitors of CDC25 phosphatases: biochemical and biological analysis 19
Development of novel amides as noncovalent inhibitors of immunoproteasomes 17
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 17
Altered Local Interactions and Long-Range Communications in UK Variant (B.1.1.7) Spike Glycoprotein 17
Exploring structural relationships between bioactive and commercial chemical space and developing target hypotheses for compound acquisition 16
Computational studies of SARS-CoV-2 3clpro: Insights from md simulations 16
A chemoinformatics search for peroxisome proliferator-activated receptors ligands revealed a new pan-agonist able to reduce lipid accumulation and improve insulin sensitivity 16
A Series of Ferulic Acid Amides Reveals Unexpected Peroxiredoxin 1 Inhibitory Activity with in vivo Antidiabetic and Hypolipidemic Effects 15
Novel inhibitors of signal transducer and activator of transcription 3 signaling pathway: an update on the recent patent literature 14
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors 14
Identification of the First PPARα/γ Dual Agonist Able to Bind to Canonical and Alternate Sites of PPARγ and to Inhibit its Cdk5-Mediated Phosphorylation 14
Chiral phenoxyacetic acid analogues inhibit colon cancer cell proliferation acting as PPARγ partial agonists 14
Binding mode exploration of b1 receptor antagonists’ by the use of molecular dynamics and docking simulation—how different target engagement can determine different biological effects 14
A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition 13
Sulfonimide and amide derivatives as novel PPARα antagonists: Synthesis, antiproliferative activity, and docking studies 13
Recent advances in developing PCSK9 inhibitors for lipid-lowering therapy 8
“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool 8
Novel Reversible Inhibitors of Xanthine Oxidase Targeting the Active Site of the Enzyme 7
New avenues in artificial-intelligence-assisted drug discovery 7
Impairment of Nucleolin Activity and Phosphorylation by a Trachylobane Diterpene from Psiadia punctulata in Cancer Cells 6
Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening 5
In Silico Drug Design and Discovery: Big Data for Small Molecule Design 4
Totale 1.095
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.104
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.104
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 1 0 0
2019/202089 35 4 1 3 3 1 0 0 4 13 20 5
2020/202194 1 0 1 4 36 14 1 1 12 7 9 8
2021/2022257 2 3 6 8 18 11 1 4 53 3 51 97
2022/2023285 36 15 17 23 15 30 7 27 40 33 22 20
2023/2024200 18 23 27 22 6 19 8 70 3 4 0 0
Totale 1.095